Product record
Osocip D / Ciprofloxacin Dexamethasone /: batches declared Not of Standard Quality
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts, Jan 2019, Jul 2026
1 batch of products named "Osocip D / Ciprofloxacin Dexamethasone /" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between June 2025 and June 2025. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.
Records by type
1 record linked to Osocip D / Ciprofloxacin Dexamethasone / in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches
| Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| E240113AMfg 2024-01 · Exp 2025-12 | Oscar Remedies Pvt. Ltd | Content of Ciprofloxacin in the sample is more (i.e 943.33% of the labelled amount) than the permissible limits. 2. identification test for the presence of Dexamethasone Sodium Phosphate. 3. The sample gives high performance liquid chromatographic identification test for the presence of Dexamethasone. 4. The content of Dexamthasone in the sample is 0.078% W/V. 5. Name of the sample: Ciprofloxacin & Dexamethasone Eye/Ear drops IP 2022.Identification | FDA Lab , MumbaiCDSCO lab | Jun 2025 |
How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of July 2026. Check any batch number.